序号 |
标题 |
次数 |
作者 |
发布时间 |
76051 |
Cl-C6-PEG2-O-CH2COOH,2245697-88-3 |
97 |
h |
2024-12-23 |
76052 |
5-TAMRA-C6-azide,1006592-61-5 |
122 |
h |
2024-12-23 |
76053 |
DiD Fluorescent Control Liposomes (Anionic) ,荧光控制脂质体(阴离子) |
145 |
axc |
2024-12-23 |
76054 |
Amino-PEG4-C6 (HCl salt),3024055-45-3 |
152 |
h |
2024-12-23 |
76055 |
Amino-PEG7-C6 (HCl salt),氨基-PEG7-C6 (HCl salt) |
100 |
h |
2024-12-23 |
76056 |
NH2-PEG8-C6-Cl,3024055-47-5 |
110 |
h |
2024-12-23 |
76057 |
NH2-PEG6-C6-Cl,1261350-61-1 |
109 |
h |
2024-12-23 |
76058 |
Me-Diazirine-C6-OH,493008-72-3 |
108 |
h |
2024-12-23 |
76059 |
Cyanine5-C6-DBCO,2360411-64-7 |
132 |
h |
2024-12-23 |
76060 |
Azido-PEG10-C6-Cl,叠氮-PEG10-C6-Cl |
226 |
h |
2024-12-23 |
76061 |
Thiol-PEG4-t-butyl ester,564476-33-1 |
99 |
h |
2024-12-23 |
76062 |
Amino-PEG12-C6,氨基-PEG12-C6 |
128 |
h |
2024-12-23 |
76063 |
Amino-PEG4-C6,3024055-44-2 |
120 |
h |
2024-12-23 |
76064 |
Thalidomide-O-C6-acid,2169266-69-5 |
85 |
h |
2024-12-23 |
76065 |
NOTA-C6-amine,NOTA-C6-氨基 |
117 |
h |
2024-12-23 |
76066 |
Me-Diazirine-C7-OH,1823865-63-9,甲基-双吖丙啶-C7-羟基 |
120 |
h |
2024-12-23 |
76067 |
m-PEG12-C11-SH,甲基-十二聚乙二醇-C11-巯基 |
98 |
h |
2024-12-23 |
76068 |
m-PEG4-C11-SH,200880-89-3,甲基-四聚乙二醇-C11-巯基 |
140 |
h |
2024-12-23 |
76069 |
m-PEG8-C11-SH,甲基-八聚乙二醇-C11-巯基 |
92 |
h |
2024-12-23 |
76070 |
(S,R,S)-AHPC-C10-NH2,CAS:2341796-74-3,(S,R,S)-AHPC-C10-胺 |
138 |
h |
2024-12-23 |
76071 |
(S,R,S)-AHPC-C9-azide,2906183-84-2,(S,R,S)-AHPC-C9-叠氮 |
128 |
h |
2024-12-23 |
76072 |
(S,R,S)-AHPC-C8-azide,2906183-83-1,(S,R,S)-AHPC-C8-叠氮 |
159 |
h |
2024-12-20 |
76073 |
m-PEG9-(CH2)8-Phosphonic acid,2900307-00-6,甲基-九聚乙二醇-C8-膦酸 |
136 |
h |
2024-12-20 |
76074 |
m-PEG2-(CH2)8-Phosphonic acid,2227008-55-9,甲基-二聚乙二醇-C8-膦酸 |
141 |
h |
2024-12-20 |
76075 |
m-PEGn-(CH2)8-Phosphonic acid,甲基-聚乙二醇-C8-膦酸 |
169 |
h |
2024-12-20 |
76076 |
Bio-PEG3-C14-鞘氨醇,生物-三聚乙二醇-C14-鞘氨醇 |
130 |
h |
2024-12-20 |
76077 |
NHS-C16-COOH,146004-84-4,琥珀酰亚胺酯-C16-酸 |
198 |
h |
2024-12-20 |
76078 |
DBCO-CONH-PEG4-Maleimide |
113 |
h |
2024-12-20 |
76079 |
cas:2130869-17-7,VCP-Eribulin , ADC试剂 |
120 |
kx |
2024-12-20 |
76080 |
cas:452072-20-7,SPP-DM1 ,抗体药物偶联物(ADC) |
138 |
kx |
2024-12-20 |
76081 |
1810001-93-4,DBM-MMAF,抗体药物偶联物(ADC) |
184 |
kx |
2024-12-20 |
76082 |
Fmoc-Gln(Trt)-PAB-PNP, ADC试剂 |
137 |
kx |
2024-12-20 |
76083 |
cas:330970-70-2,Alloc-Val-Ala-OH,((烯丙氧基)羰基)-L-戊基-L-丙氨酸 |
145 |
kx |
2024-12-20 |
76084 |
cas:2055041-40-0,Azido-PEG1-Val-Cit-PAB-OH, ADC试剂 |
98 |
kx |
2024-12-20 |
76085 |
DBCO-C4-Val-Cit-PABC-PNP,抗体药物偶联物(ADC) |
144 |
kx |
2024-12-20 |
76086 |
cas:2243566-44-9,Azidoethyl-SS-propionic NHS ester,叠氮-二硫键-琥珀酰亚胺酯 |
173 |
kx |
2024-12-20 |
76087 |
MEL-tri-EG-OPFP,抗体药物偶联物(ADC) |
210 |
kx |
2024-12-20 |
76088 |
Pomalidomide-C6-COOH,2225940-50-9 |
110 |
wyh |
2024-12-20 |
76089 |
cas:799840-96-3,Maytansinoid DM4,N2'-去乙酰基-N2'-(4-巯基-4-甲基-1-氧代戊基)-6-甲基美登素 |
158 |
kx |
2024-12-20 |
76090 |
Cl-C6-PEG1-O-CH2COOH,2231744-57-1,氯-C6-一聚乙二醇-O-乙酸 |
111 |
wyh |
2024-12-20 |
76091 |
Amino-PEG1-C6 (HCl salt),1802310-46-8 |
110 |
wyh |
2024-12-20 |
76092 |
cas:114390-30-6,N-(Iodoacetamido)-Doxorubicin, ADC试剂 |
143 |
kx |
2024-12-20 |
76093 |
Azido-PEG5-C6-Cl,1261238-21-4,叠氮-五聚乙二醇-C6-氯 |
112 |
wyh |
2024-12-20 |
76094 |
cas:1226050-10-7,N-(2-(4-Chlorophenoxy)ethyl)-4-formylbenzamide |
153 |
kx |
2024-12-20 |
76095 |
DBCO-C3-Maleimide,1629057-08-4 |
135 |
h |
2024-12-20 |